Abstract

Vascular access devices (VADs) are vital in cancer treatment for intravenous fluids like vesicant drugs, parenteral nutrition, frequent blood testing, and blood transfusion. A peripherally inserted central catheter (PICC) is one type of VAD popularly used for vascular access among cancer patients due to patient comfort, ease of insertion, lesser risks of complications, and cost-effectiveness. Current guidelines do not recommend PICC placement for patients with an eGFR lower than 45 mL/min/1.73 m2 with a diagnosis of chronic kidney disease (CKD) stage 3b or higher for vessel preservation for possible future arteriovenous fistula (AVF) need.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call